Smith MA - Search Results

1

Pharmacogenomics in the treatment of inflammatory bowel disease.

Smith MA, Marinaki AM, Sanderson JD. Smith MA, et al. Pharmacogenomics. 2010 Mar;11(3):421-37. doi: 10.2217/pgs.10.4. Pharmacogenomics. 2010. PMID: 20235796 Review.

2

Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease.

Ansari A, Aslam Z, De Sica A, Smith M, Gilshenan K, Fairbanks L, Marinaki A, Sanderson J, Duley J. Ansari A, et al. Aliment Pharmacol Ther. 2008 Sep 15;28(6):749-57. doi: 10.1111/j.1365-2036.2008.03768.x. Aliment Pharmacol Ther. 2008. PMID: 18557988

3

Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.

Ansari A, Arenas M, Greenfield SM, Morris D, Lindsay J, Gilshenan K, Smith M, Lewis C, Marinaki A, Duley J, Sanderson J. Ansari A, et al. Aliment Pharmacol Ther. 2008 Oct 15;28(8):973-83. doi: 10.1111/j.1365-2036.2008.03788.x. Aliment Pharmacol Ther. 2008. PMID: 18616518 Clinical Trial.

4

Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease.

Smith MA, Marinaki AM, Arenas M, Shobowale-Bakre M, Lewis CM, Ansari A, Duley J, Sanderson JD. Smith MA, et al. Aliment Pharmacol Ther. 2009 Aug 15;30(4):375-84. doi: 10.1111/j.1365-2036.2009.04057.x. Epub 2009 Jun 3. Aliment Pharmacol Ther. 2009. PMID: 19500084

5

Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease.

Smith MA, Irving PM, Marinaki AM, Sanderson JD. Smith MA, et al. Aliment Pharmacol Ther. 2010 Jul;32(2):119-30. doi: 10.1111/j.1365-2036.2010.04330.x. Epub 2010 Apr 16. Aliment Pharmacol Ther. 2010. PMID: 20412066 Review.

6

Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.

van Asseldonk DP, Sanderson J, de Boer NK, Sparrow MP, Lémann M, Ansari A, Almer SH, Florin TH, Gearry RB, Mulder CJ, Mantzaris G, van Bodegraven AA; Thiopurine Task Force Interest Group. van Asseldonk DP, et al. Dig Liver Dis. 2011 Apr;43(4):270-6. doi: 10.1016/j.dld.2010.09.001. Epub 2010 Oct 8. Dig Liver Dis. 2011. PMID: 20934926 Review.

7

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.

Smith MA, Blaker P, Marinaki AM, Anderson SH, Irving PM, Sanderson JD. Smith MA, et al. J Crohns Colitis. 2012 Oct;6(9):905-12. doi: 10.1016/j.crohns.2012.02.007. Epub 2012 Mar 3. J Crohns Colitis. 2012. PMID: 22386736

8

The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinic.

Smith M, Blaker P, Patel C, Marinaki A, Arenas M, Escuredo E, Anderson S, Irving P, Sanderson J. Smith M, et al. Int J Clin Pract. 2013 Feb;67(2):161-9. doi: 10.1111/ijcp.12039. Epub 2012 Dec 17. Int J Clin Pract. 2013. PMID: 23253089

9

Mechanism of allopurinol induced TPMT inhibition.

Blaker PA, Arenas-Hernandez M, Smith MA, Shobowale-Bakre EA, Fairbanks L, Irving PM, Sanderson JD, Marinaki AM. Blaker PA, et al. Among authors: smith ma. Biochem Pharmacol. 2013 Aug 15;86(4):539-47. doi: 10.1016/j.bcp.2013.06.002. Epub 2013 Jun 14. Biochem Pharmacol. 2013. PMID: 23770457

10

Management of inflammatory bowel disease in pregnancy.

Smith MA, Sanderson JD. Smith MA, et al. Obstet Med. 2010 Jun;3(2):59-64. doi: 10.1258/om.2010.100010. Epub 2010 Jun 3. Obstet Med. 2010. PMID: 27582844 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,161 results

Search Page

Filters